{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:04:06Z","timestamp":1772769846872,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T00:00:00Z","timestamp":1719705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.breast.2024.103765","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T02:26:38Z","timestamp":1720059998000},"page":"103765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer"],"prefix":"10.1016","volume":"77","author":[{"given":"Eleonora","family":"Pagan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eraldo Oreste","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Graffeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Borner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Rabaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Freschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Cretella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Seles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Farolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edda","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Ciccarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Favaretto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedemann","family":"Honecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Franzetti-Pellanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari","family":"Gelber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Bagnardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4724-1197","authenticated-orcid":false,"given":"Karin","family":"Ribi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2024.103765_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"issue":"6","key":"10.1016\/j.breast.2024.103765_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3322\/caac.21583","article-title":"Breast cancer statistics, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2024.103765_bib3","series-title":"Ecis - European cancer information System - incidence and Mortality","year":"2020"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10549-016-3983-9","article-title":"Long-term outcome in young women with breast cancer: a population-based study","volume":"160","author":"Fredholm","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"27","key":"10.1016\/j.breast.2024.103765_bib5","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1200\/JCO.2015.65.8013","article-title":"Subtype-dependent relationship between young age at diagnosis and breast cancer survival","volume":"34","author":"Partridge","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4048\/jbc.2019.22.e13","article-title":"Young patients with hormone receptor-positive breast cancer have a higher long-term risk of breast cancer specific death","volume":"22","author":"Fu","year":"2019","journal-title":"J Breast Cancer"},{"issue":"11","key":"10.1016\/j.breast.2024.103765_bib7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2022.07.007","article-title":"ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)","volume":"33","author":"Paluch-Shimon","year":"2022","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.breast.2024.103765_bib8","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","article-title":"Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study","volume":"8","author":"Heer","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.breast.2024.103765_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice Guideline focused update","volume":"37","author":"Burstein","year":"2019","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2024.103765_bib10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.breast.2024.103765_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","article-title":"Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review","volume":"134","author":"Murphy","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103765_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.breast.2022.01.012","article-title":"Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review","volume":"62","author":"Yussof","year":"2022","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.breast.2024.103765_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","article-title":"Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer","volume":"126","author":"Hershman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.breast.2024.103765_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-020-06003-8","article-title":"International variation in breast cancer incidence and mortality in young women","volume":"186","author":"Sopik","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103765_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/PPA.S126651","article-title":"Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review","volume":"11","author":"Moon","year":"2017","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"10.1016\/j.breast.2024.103765_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10549-017-4561-5","article-title":"Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review","volume":"167","author":"Lambert","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.breast.2024.103765_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-018-05073-z","article-title":"Identifying adherence barriers to oral endocrine therapy among breast cancer survivors","volume":"174","author":"Paranjpe","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103765_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.breast.2021.05.005","article-title":"The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: a qualitative systematic review and thematic synthesis","volume":"58","author":"Peddie","year":"2021","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010107","article-title":"Potentially modifiable factors associated with adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review","volume":"13","author":"Toivonen","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.breast.2024.103765_bib21","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1007\/s00520-020-05585-9","article-title":"Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory","volume":"28","author":"AlOmeir","year":"2020","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-016-3788-x","article-title":"Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)","volume":"157","author":"Hershman","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.breast.2024.103765_bib23","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1200\/JOP.2016.018630","article-title":"Investigating associations between health-related quality of life and endocrine therapy underuse in women with early-stage breast cancer","volume":"13","author":"Pinheiro","year":"2017","journal-title":"J Oncol Pract"},{"issue":"5","key":"10.1016\/j.breast.2024.103765_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1634\/theoncologist.2015-0349","article-title":"Patient-reported outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women with early stage breast cancer","volume":"21","author":"Kadakia","year":"2016","journal-title":"Oncol"},{"issue":"2","key":"10.1016\/j.breast.2024.103765_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10549-014-2961-3","article-title":"Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry","volume":"145","author":"Stanton","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.breast.2024.103765_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2003.07.071","article-title":"Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer","volume":"21","author":"Partridge","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2024.103765_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4048\/jbc.2023.26.e22","article-title":"Investigation of factors affecting adherence to adjuvant hormone therapy in early-stage breast cancer patients: a comprehensive systematic review","volume":"26","author":"Yang","year":"2023","journal-title":"J Breast Cancer"},{"issue":"3","key":"10.1016\/j.breast.2024.103765_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10549-022-06810-1","article-title":"Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer","volume":"197","author":"Rosenberg","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103765_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.breast.2019.07.001","article-title":"Fertility concerns, preservation strategies and quality of life in young women with breast cancer: baseline results from an ongoing prospective cohort study in selected European Centers","volume":"47","author":"Ruggeri","year":"2019","journal-title":"Breast"},{"issue":"6","key":"10.1016\/j.breast.2024.103765_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jnci\/dji069","article-title":"The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer","volume":"97","author":"Stanton","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.breast.2024.103765_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/pon.1806","article-title":"Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy","volume":"20","author":"Terhorst","year":"2011","journal-title":"Psycho Oncol"},{"issue":"6","key":"10.1016\/j.breast.2024.103765_bib32","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/1097-0142(19910915)68:6<1406::AID-CNCR2820680638>3.0.CO;2-2","article-title":"CAncer Rehabilitation Evaluation System--short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument","volume":"68","author":"Schag","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00435432","article-title":"The CARES: a generic measure of health-related quality of life for patients with cancer","volume":"1","author":"Ganz","year":"1992","journal-title":"Qual Life Res"},{"issue":"18","key":"10.1016\/j.breast.2024.103765_bib34","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.breast.2024.103765_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv202","article-title":"Impact of fertility concerns on tamoxifen initiation and persistence","volume":"107","author":"Llarena","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"27","key":"10.1016\/j.breast.2024.103765_bib36","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2016.72.0946","article-title":"Treatment efficacy, adherence, and quality of life among women younger than 35 Years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trials","volume":"35","author":"Saha","year":"2017","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.breast.2024.103765_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv202","article-title":"Impact of fertility concerns on tamoxifen initiation and persistence","volume":"107","author":"Llarena","year":"2015","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib38","doi-asserted-by":"crossref","first-page":"pkz008","DOI":"10.1093\/jncics\/pkz008","article-title":"Cancer treatment-related infertility: a critical review of the evidence","volume":"3","author":"Poorvu","year":"2019","journal-title":"JNCI Cancer Spectr"},{"issue":"4","key":"10.1016\/j.breast.2024.103765_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.soc.2023.05.012","article-title":"Fertility and sexual health in young women with early-stage breast cancer","volume":"32","author":"Lipsyc-Sharf","year":"2023","journal-title":"Surg Oncol Clin N Am"},{"issue":"11","key":"10.1016\/j.breast.2024.103765_bib40","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamasurg.2020.3325","article-title":"Association of breast cancer surgery with quality of life and psychosocial well-being in young breast cancer survivors","volume":"155","author":"Rosenberg","year":"2020","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.breast.2024.103765_bib41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12529-020-09908-2","article-title":"The patient's voice: adherence, symptoms, and distress related to adjuvant endocrine therapy after breast cancer","volume":"27","author":"Jacobs","year":"2020","journal-title":"Int J Behav Med"},{"key":"10.1016\/j.breast.2024.103765_bib42","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2147\/PPA.S319087","article-title":"A survey of potentially modifiable patient-level factors associated with self-report and objectively measured adherence to adjuvant endocrine therapies after breast cancer","volume":"15","author":"Toivonen","year":"2021","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11764-020-00908-5","article-title":"How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support","volume":"15","author":"Berkowitz","year":"2021","journal-title":"J Cancer Surviv"},{"issue":"4","key":"10.1016\/j.breast.2024.103765_bib44","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/annonc\/mdr330","article-title":"Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time","volume":"23","author":"Cluze","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00520-020-05476-z","article-title":"Patient interactive digital support for women with adjuvant endocrine therapy in order to increase compliance and quality of life","volume":"29","author":"Bergqvist","year":"2021","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.breast.2024.103765_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11764-018-0682-z","article-title":"Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial","volume":"12","author":"Graetz","year":"2018","journal-title":"J Cancer Surviv"},{"issue":"1","key":"10.1016\/j.breast.2024.103765_bib47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1186\/s12885-023-11242-1","article-title":"Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study","volume":"23","author":"Gernier","year":"2023","journal-title":"BMC Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624000961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624000961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T14:57:39Z","timestamp":1728399459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977624000961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"alternative-id":["S0960977624000961"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2024.103765","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2024.103765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103765"}}